Sun Pharma turns volatile after three observations for Halol facility

The stock was up 3.5% at Rs 561 on the BSE at 02:34 pm, after the company said the USFDA issued Form 483, with three observations, for its Halol facility in Gujarat.

Sun Pharmaceutical Industries has turned volatile, trading 3.5% higher at Rs 561 on the BSE at 02:34 pm, after the company said the US Food and Drug Administration (USFDA) issued Form 483, with three observations, for its Halol facility in Gujarat.

The stock rallied nearly 6% to Rs 572 in intra-day trade, has fallen to Rs 550 at 02:23 pm post announcements. The company informed the stock exchanges at around 02:19 pm.

In past two trading day, the stock more than 7% from Rs 525 on February 21, 2018, after falling 6% on Wednesday.